Hood River Capital Management LLC Deciphera Pharmaceuticals, Inc. Transaction History

Hood River Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$7.7 - $37.13 $1.67 Million - $8.04 Million	-216,557 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$26.46 - $37.15 $238,404 - $334,721	-9,010 Reduced 3.99%	216,557 $7.36 Million
Q2 2021 Aug 13, 2021	SELL	$32.73 - $47.95 $113,671 - $166,530	-3,473 Reduced 1.52%	225,567 $8.26 Million
Q1 2021 May 17, 2021	SELL	$40.39 - $56.73 $7.94 Million - $11.2 Million	-196,621 Reduced 46.19%	229,040 $10.3 Million
Q4 2020 Feb 16, 2021	BUY	$51.77 - $66.18 $9.02 Million - $11.5 Million	174,280 Added 69.33%	425,661 $24.3 Million
Q3 2020 Nov 16, 2020	SELL	$43.8 - $58.16 $247,469 - $328,604	-5,650 Reduced 2.2%	251,381 $12.9 Million
Q2 2020 Aug 14, 2020	BUY	$37.05 - $65.03 $9.52 Million - $16.7 Million	257,031 New	257,031 $15.4 Million

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Hood River Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Hood River Capital Management LLC with notifications on news.